TheEdgeResearch
Home / Stocks / HBRM

Herborium Group, Inc. (HBRM)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$1.1M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
8.81
52-Wk Range
0.00001-0.0001
CEO
Agnes Olszewski
Country
US
Currency
USD

Herborium Group, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sugar Land, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1.1M. On trailing twelve-month figures it carries a trailing P/E of -4.73, a net margin of -29.3%. Its beta of 8.81 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-4.73
Price / Sales
1.39
Price / Book
-0.25
EV / EBITDA
-7.43
Gross margin
61.0%
Operating margin
-36.9%
Net margin
-29.3%
Return on equity
Debt / equity
-0.25
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
1998-07-13
Headquarters
Sugar Land, TX, US
About Herborium Group, Inc.

Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals. Its product range includes dermatological solutions like AcnEase, an herbal treatment designed to alleviate symptoms associated with hormonal acne and various forms of Rosacea. The company also offers the AcnEase Skin Management System, intended to diminish acne marks and scars. Furthermore, Herborium provides non-prescription sexual health and performance products. These serve as alternatives for specific sexual dysfunctions that may arise from cardiovascular conditions, the use of antidepressants, or surgical procedures such as hysterectomies. The company also offers energy-boosting products, notably Lasting Energy. This herbal supplement aims to reduce hangover effects, counteract jet lag, and address general energy depletion caused by intense physical activities, high stress levels, prolonged sexual engagements, or other enduring or temporary physical demands. Additional products in its portfolio include the Liver Activator Series for managing liver damage; ProstAid, a natural remedy specifically formulated for Benign Prostate Hyperplasia (BPH); and CardioVitae, a fermentation-based product utilizing a Lucidium-derived cell line to target cardio-pulmonary insufficiencies. Herborium Group, Inc. distributes its products across the United States, the United Kingdom, and mainland Europe, utilizing a network of distributors, specialty retailers, and its e-commerce platform. The company was founded in 2000 and has its principal office located in Fort Lee, New Jersey.

Comparable companies

Herborium Group, Inc. is most often compared with the following Healthcare names:

BINPBMCSBMMJCTTHEDXCGXXYLVVEFMJNAPCYNSRUTF
More research on HBRM
HBRM technical analysis HBRM TheEdge Score Compare against peers
Open full interactive analysis & DCF →